Cumberland Pharmaceuticals (CPIX) Deferred Taxes (2012 - 2020)
Cumberland Pharmaceuticals (CPIX) reported Deferred Taxes of $21802.0 for Q4 2020, little changed on a YoY basis from $21803.0 in Q1 2020, and little changed sequentially from $21803.0 in Q4 2019.
Cumberland Pharmaceuticals (CPIX) Deferred Taxes (2012 - 2020) Analysis & Trends
Cumberland Pharmaceuticals (CPIX) has 9 years of Deferred Taxes data on file, last reported at $21802.0 in Q4 2020.
- For the quarter ending Q4 2020, Deferred Taxes changed 0.0% year-over-year to $21802.0; the trailing twelve-month figure through Dec 2020 stood at $21802.0 (down 66.67% YoY), and the FY2020 full-year result was $21802.0, down 66.67% from the prior year.
- Deferred Taxes was little changed at $21802.0 in Q4 2020, from $21803.0 in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $3.5 million in Q2 2017 to a low of -$87210.0 in Q4 2017.
- A 5-year average of $454129.9 and a median of $81886.0 in 2018 frame the typical range for Deferred Taxes.
- Peak annual rise in Deferred Taxes reached 1294.48% in 2016, while the deepest fall reached 109.66% in 2016.
- Tracing CPIX's Deferred Taxes over 5 years: stood at -$43109.0 in 2016, then tumbled by 102.3% to -$87210.0 in 2017, then soared by 193.9% to $81886.0 in 2018, then plunged by 73.37% to $21803.0 in 2019, then declined by 0.0% to $21802.0 in 2020.
- Business Quant data shows CPIX's Deferred Taxes at $21802.0 in Q4 2020, $21803.0 in Q4 2019, and $43605.0 in Q1 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -22.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 34.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 25.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -69.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -61.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Cumberland Pharmaceuticals | 104.57 Mn | 93.23 Mn | 7.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 21,802.00 |
| Dec 31, 2019 | 21,803.00 |
| Mar 31, 2019 | 43,605.00 |
| Dec 31, 2018 | 81,886.00 |
| Dec 31, 2017 | -87,210.00 |
| Jun 30, 2017 | 3.54 Mn |
| Mar 31, 2017 | 758,112.00 |
| Dec 31, 2016 | -43,109.00 |
| Sep 30, 2016 | 129,622.00 |
| Jun 30, 2016 | 329,000.00 |
| Mar 31, 2016 | 204,067.00 |
| Dec 31, 2015 | 446,236.00 |
| Sep 30, 2015 | 20,398.00 |
| Jun 30, 2015 | 23,593.00 |
| Dec 31, 2014 | -273,075.00 |
| Sep 30, 2014 | -36,255.00 |
| Dec 31, 2013 | -1.50 Mn |
| Sep 30, 2013 | -141,745.00 |
| Mar 31, 2013 | 65,413.00 |
| Dec 31, 2012 | -829,846.00 |